Literature DB >> 11911503

New findings on the neuropathology of multiple system atrophy.

Eduardo E Benarroch1.   

Abstract

Multiple system atrophy (MSA) provides a typical example of the integrative role of the central autonomic network in controlling cardiovascular, respiratory, bladder and gastrointestinal functions. There is increasing evidence that neurochemically defined neuronal groups of the brainstem are selectively affected in MSA to a much greater degree than in Parkinson's disease. These include the catecholaminergic neurons of the rostral ventrolateral medulla (C1 group) which project to the intermediolateral cell column and are involved in modulation of sympathetic vasomotor outflow, and noradrenergic neurons of the caudal ventrolateral medulla (A1 group) projecting to the magnocellular nuclei of the hypothalamus and regulating vasopressin (AVP) release. Loss of these groups of neurons may, at least in part, explain the development of orthostatic hypotension, baroreflex dysfunction, and impaired reflex AVP release in response to hypotension. There is preliminary evidence that cardiovagal neurons of the ventrolateral portion of the nucleus ambiguus, distinct from the branchimotor neurons of the compact region, may also be affected in MSA. Loss of cholinergic neurons in the medullary arcuate nucleus, considered by some to be the homologous to the central chemosensitive region of the ventral medullary surface, may contribute to disturbances in automatic ventilation, particularly during sleep, in patients with MSA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11911503     DOI: 10.1016/s1566-0702(01)00374-5

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  15 in total

Review 1.  Clinical Relevance of Orthostatic Hypotension in Neurodegenerative Disease.

Authors:  Katherine E McDonell; Cyndya A Shibao; Daniel O Claassen
Journal:  Curr Neurol Neurosci Rep       Date:  2015-12       Impact factor: 5.081

2.  Ventilatory and cardiovascular responses to hypercapnia and hypoxia in multiple-system atrophy.

Authors:  Axel Lipp; James D Schmelzer; Phillip A Low; Bruce D Johnson; Eduardo E Benarroch
Journal:  Arch Neurol       Date:  2010-02

Review 3.  Synucleinopathies.

Authors:  Elizabeth A Coon; Wolfgang Singer
Journal:  Continuum (Minneap Minn)       Date:  2020-02

4.  [Segmental dysfunction of sweating in multiple system atrophy].

Authors:  C Saft; J Andrich; T Müller; H Przuntek; M Stücker
Journal:  Hautarzt       Date:  2005-08       Impact factor: 0.751

Review 5.  The role of serotonin in respiratory function and dysfunction.

Authors:  Gérard Hilaire; Nicolas Voituron; Clément Menuet; Ronaldo M Ichiyama; Hari H Subramanian; Mathias Dutschmann
Journal:  Respir Physiol Neurobiol       Date:  2010-08-27       Impact factor: 1.931

6.  Systemic postganglionic adrenergic studies do not distinguish Parkinson's disease from multiple system atrophy.

Authors:  Axel Lipp; Paola Sandroni; Phillip A Low
Journal:  J Neurol Sci       Date:  2009-04-05       Impact factor: 3.181

Review 7.  Perspectives on the rapid eye movement sleep switch in rapid eye movement sleep behavior disorder.

Authors:  Vetrivelan Ramaligam; Michael C Chen; Clifford B Saper; Jun Lu
Journal:  Sleep Med       Date:  2013-06-13       Impact factor: 3.492

8.  Abnormal baroreceptor-mediated vasopressin release as possible marker in early diagnosis of multiple system atrophy.

Authors:  K Deguchi; I Sasaki; T Touge; M Tsukaguchi; H Takeuchi; S Kuriyama
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-01       Impact factor: 10.154

9.  Is There a Difference in Autonomic Dysfunction Between Multiple System Atrophy Subtypes?

Authors:  Divyani Garg; Achal Kumar Srivastava; Ashok Kumar Jaryal; Roopa Rajan; Akanksha Singh; Awadh Kishor Pandit; Deepti Vibha; Garima Shukla; Ajay Garg; Ravindra Mohan Pandey; Kameshwar Prasad
Journal:  Mov Disord Clin Pract       Date:  2020-04-09

10.  Oligodendroglial alpha-synucleinopathy and MSA-like cardiovascular autonomic failure: experimental evidence.

Authors:  Daniela Kuzdas; Sylvia Stemberger; Stefano Gaburro; Nadia Stefanova; Nicolas Singewald; Gregor K Wenning
Journal:  Exp Neurol       Date:  2013-02-08       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.